Fast Muscle Activation and Stepping Training (FAST) Post-stroke (FAST)

April 27, 2026 updated by: Jayne Garland, University of British Columbia

Effectiveness of Fast Muscle Activation and Stepping Training (FAST) on Balance and Mobility Post-stroke

The purpose of this study is to determine whether FAST (Fast muscle Activation and Stepping Training) exercises will improve walking balance in individuals after stroke to a greater extent than usual care.

Hypothesis: The primary hypothesis is that improvements in walking balance will be larger following 12 sessions of FAST exercise retraining compared to usual care in persons in the sub-acute phase after stroke.

Study Overview

Status

Completed

Conditions

Detailed Description

It is estimated that 75-80% of individuals who have had a stroke will survive the acute event and be left with residual disability. Regaining independence in standing and walking is of utmost importance for patients recovering from stroke. Walking balance requires muscles in the legs and trunk to contract quickly if people lose their balance. Physical therapy plays a key role in the rehabilitation of walking balance in individuals after stroke. Given that maintaining one's balance requires fast muscle activity, rehabilitation post-stroke should focus on speed of movement. Thus we are proposing to compare a program that emphasizes speed of movement, Fast muscle Activation and Stepping Training versus an active control (usual care).

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • North Vancouver, British Columbia, Canada, V7L 2L7
        • Lions Gate Hospital
      • Vancouver, British Columbia, Canada, V5P 3L6
        • Holy Family Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Study population: Subjects with a diagnosis of stroke

Inclusion Criteria:

  • first stroke (<6 months ago)
  • presence of hemiparesis in the lower extremity
  • minimum Berg Balance Score (BBS) of 30/56
  • cognitive ability to give informed consent

Exclusion Criteria:

  • bilateral stroke, or a previous stroke in the other hemisphere
  • severe co-morbidity that is likely to dominate the pattern of care
  • co-existing peripheral neuropathies or disorders of the vestibular apparatus
  • musculoskeletal problems
  • global aphasia or receptive aphasia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual care
The usual care will consist of strength training, endurance, range of motion, patient education, weight shifting in standing and gait re-training.
The Usual Care program will consist of 2 sessions a week for 45 minutes for a 6 week duration.
Experimental: FAST protocol
The Fast muscle activation and stepping training will be the Experimental arm of this trial. This program will be exercises emphasizing speed of movement.
The Fast muscle activation and Stepping Training (FAST protocol) will be exercises emphasizing speed, small squats and protective steps, that will be progressed. This program will be 2 sessions a week for 45 minutes for 6 weeks in duration.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Community Balance and Mobility Scale
Time Frame: Pre treatment and Post treatment (6 weeks)
Pre treatment and Post treatment (6 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait assessment
Time Frame: Pre treatment, Post treatment (6 weeks) and Retention (+1 month after treatment)
Self selected speed and changes in electromyography
Pre treatment, Post treatment (6 weeks) and Retention (+1 month after treatment)
Physiological balance assessment by internal and external perturbations
Time Frame: Pre treatment, Post treatment (6 weeks) and Retention (+1 month after treatment)
Electromyography and Center of pressure changes
Pre treatment, Post treatment (6 weeks) and Retention (+1 month after treatment)
Activities-specific Balance Confidence Scale
Time Frame: Pre treatment, Post treatment (6 weeks) and Retention (+1 month after treatment)
Pre treatment, Post treatment (6 weeks) and Retention (+1 month after treatment)
Community Balance and Mobility Scale
Time Frame: Post treatment and Retention (+1 month after treatment)
Post treatment and Retention (+1 month after treatment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: S. Jayne Garland, PT, PhD, University of British Columbia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2012

Primary Completion (Actual)

March 31, 2017

Study Completion (Actual)

June 30, 2017

Study Registration Dates

First Submitted

April 5, 2012

First Submitted That Met QC Criteria

April 5, 2012

First Posted (Estimated)

April 9, 2012

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

June 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Usual Care

Subscribe